J0742 – Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0742
- Long description
- Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
- Short description
- Inj imip 4 cilas 4 releb 2mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- July 1, 2020
- Last change
- July 1, 2020 – No change
Frequently asked questions
What is HCPCS code J0742?
J0742 is a HCPCS Level II code for injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg.
Does Medicare cover J0742?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0725 – Injection, chorionic gonadotropin, per 1,000 usp units
- J0735 – Injection, clonidine hydrochloride, 1 mg
- J0736 – Injection, clindamycin phosphate, 300 mg
- J0737 – Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
- J0738 – Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0739 – Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0740 – Injection, cidofovir, 375 mg
- J0741 – Injection, cabotegravir and rilpivirine, 2mg/3mg
- J0743 – Injection, cilastatin sodium; imipenem, per 250 mg
- J0744 – Injection, ciprofloxacin for intravenous infusion, 200 mg
- J0745 – Injection, codeine phosphate, per 30 mg
- J0750 – Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
- J0751 – Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
- J0752 – Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0759 – Injection, clevidipine butyrate, 1 mg
- J0760 – Injection, colchicine, per 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.